A study of prescribing pattern of drugs in patients of cardiovascular emergencies at a tertiary care hospital of Western Maharashtra

Kiran P. Vakade, Vandana M. Thorat, Chitra C. Khanwelkar, Sujata A. Jadhav, Vijayprasad M. Sanghishetti


Background: The main objective of drug utilization research is to assess the rationality of drug use. Recently it has been found that cardiovascular disease is the most frequent cause of morbidity and mortality throughout the world. The objective of present study was to focus on the trends in prescribing patterns of most frequently treated cardiovascular emergencies.

Methods: A retrospective descriptive study was carried out in cardiovascular emergency patients. From the medical records the following data was collected:  Distribution of cardiovascular emergencies (age and sex wise), most common cardiovascular emergencies treated, outcome of each patient, average duration of stay in the hospital and drugs prescribed per patient,  correlation of clinical outcome with treatment if possible, drug utilization trend in cardiovascular emergencies. From the data, master chart was prepared for data analysis.

Results: Total 82 patients case records were studied. Myocardial infarction (50%) was the most common cardiovascular emergency treated during study period followed by unstable angina (36.58%).  Male to female ratio was 1.83. Average hospital stay was found 5.75 days. The average number of drugs per patient was 8.4.  Hypertension (42.24%) and diabetes mellitus (19.51%) were the most common comorbidities found associated with cardiovascular emergencies. Aspirin clopidogrel combination (80.49%), enoxaparin (75.61%), atorvastatin (73.17%), glyceryl trinitrate (73.17%) were the most commonly prescribed drugs. The utilization rate of ACE inhibitors and ARBs (56.10%) was found higher than that of beta blockers (28.05%). Stool softeners (52.46%) and anxiolytics (28.58%) were the most commonly used non-cardiovascular drugs. Improvement was seen in 82.93% patients.

Conclusions: Protocol of management strategy of cardiovascular emergencies in our tertiary care hospital was found near to standard recommended guidelines.




Cardiovascular emergencies, Drug utilization, Myocardial infarction

Full Text:



Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). The lancet. 2000;356(9226):279-84.

Gupta R. Burden of coronary heart disease in India. Indian heart journal. 2005;57:632-8.

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The lancet. 2004;364(9438):937-52.

Kumari R, Idris MZ, Bhushan V, Khanna A, Agrawal M, Singh SK. Assessment of prescription pattern at the public health facilities of Lucknow district. Indian journal of pharmacology. 2008;40(6):243-7.

Gross F. Drug utilization Theory and practice the present situation in the Federal Republic of Germany. European Journal of Clinical Pharmacology. 1981;19(6):387-94.

Vijayakumar T, Sathyavati D, Subhashini T, Grandhi S, Dhanaraju M. Assessment of prescribing trends and rationality of drug prescribing. International Journal of Pharmacology. 2011;7(1):140-3.

Ramsay LE. Bridging the gap between clinical pharmacology and rational drug prescribing. British journal of clinical pharmacology. 1993;35(6):575-6.

Alam K, Mishra P, Prabhu M, Shankar PR, Palaian S, Bhandari RB. A study on rational drug prescribing and dispensing in outpatients in a tertiary care teaching hospital of Western Nepal. Kathmandu University Medical Journal. 2006;4(16):436-43.

Salman MT, Akram MF, Rahman S, Khan FA, Haseen MA, Khan SW. Drug prescribing pattern in surgical wards of a teaching hospital in North India. Indian Journal for the Practising Doctor. 2008;5:5-6.

Shankar PR, Kumar P, Rana MS, Partha P, Upadhayay DK, Dubey AK. Morbidity profile and drug utilization in a sub-health post in Western Nepal. Calicut Medical Journal. 2004;2(4):4.

Anis AH, Carruthers SG, Carter AO, Kierulf J. Variability in prescription drug utilization: issues for research. CMAJ: Canadian Medical Association Journal. 1996;154(5):635.

Taskeen M, Anitha N, Ali SR, Bharath R, Khan AB. A study on rational drug prescribing pattern in geriatric patients in hyderabad metropolitan. JDDTJ. 2012;2:109-13.

Laporte JR, Baksaas I, Lunde PKM. General background. In Dukes MNG (Edn) Drug utilization studies methods and uses, WHO regional publication. European series No.45 Copenhagen WHO. 1993

Weidner G. Why do men get more heart disease than women? An international perspective J Am Coll Health. 2000;48(6):291-4.

Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation. 1999;99(9):1165-72.

Chrysohoou C, Panagiotakos DB, Pitsavos C, Kokkinos P, Marinakis N, Stefanadis C. Gender differences on the risk evaluation of acute coronary syndromes: the Cardio 2000 study. Prev Cardiol. 2003;6(2):71-7.

Mendelsohn ME, Karas RH. The Protective Effects of estrogen on the Cardiovascular System N Engl J Med. 1999; 340:1801-11.

Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res. 2006;124(3):235-44.

Karthikeyan G, Xavier D, Prabhakaran D, Pais P Perspectives on the management of coronary artery disease in India Heart. 2007;93:1334-8.

Martinez M, Agusti A, Arnau J, Vidal X, Laporte JR. Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period. European Journal of Clinical Pharmacology. 1998;54(3):203-8.

Scott IA, Heath K, Harper C, Clough A. An Australian comparison of specialist care of acute myocardial infarction. International Journal for Quality in Health Care. 2003;15(2):155-61.

Prabhakaran D, Jeemon P, Mohanan P, Govindan U, Geevar Z, Chaturvedi V. Management of acute coronary syndromes in secondary care settings in Kerala: Impact of quality improvement programme. Natl Med J India. 2008;21:62-6.

Nagabushan H, Roopavedi HS, Prakash GM, Pankaja RA. prospective study of drug utilization pattern in cardiac intensive care unit at a tertiary care teaching hospital Int J Basic Clin Pharmacol. 2015;4(3):579-83.

Menon V, Rumsfeld JS, Roe MT, Cohen MG, Peterson ED, Brindis RG. Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromes. The American Journal of Medicine. 2006;119(7):584-90.

Venturini F, Romero M, Tognoni G. Acute myocardial infarction treatments in 58 Italian hospitals: a drug utilization survey. The Annals of pharmacotherapy. 1995;29(11):1100.

Martinez M, Agusti A, Arnau J, Vidal X, Laporte JR. Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period. European Journal of Clinical Pharmacology. 1998;54(3):203-8.

Kizer JR, Cannon CP, McCabe CH, Mueller HS, Schweiger MJ, Davis VG. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. American heart journal. 1999;137(1):79-92.

Escosteguy CC, Portela MC, Vasconcellos MTL, Medronho RA. Pharmacological management of acute myocardial infarction in the municipal district of Rio de Janeiro. Sao Paulo Medical Journal. 2001;119(6):193-9.

Friedman BM. Early interventions in the management of acute uncomplicated myocardial infarction. Western journal of medicine. 1995;162(1):19-27.

Borzak S. Intravenous nitroglycerin for acute myocardial infarction. Henry Ford Hosp Med J. 1991;39(3-4):206-9.